This study mainly examined the changes in CAT levels and oxidative stress in the brain tissue during AGO treatment in a depression mouse model, determined the presence or absence of a correlation between this change and depression and anxious behavior in mice, and investigated whether this change would be affected by DFX. This evidence concerns the gene CAT and depressive symptom measurement.